Conventus Orthopaedics Receives $12MM Venture Loan

Conventus Orthopaedics closed a US $12MM venture loan from Horizon Technology Finance. Funds will support general working capital as Conventus continues to develop its proprietary Nitinol technology, which is designed to offer intramedullary support in the treatment of periarticular fractures.

Specifically, the financing will help to further...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us